Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2007
12/19/2007EP1867343A2 Novel compounds
12/19/2007EP1867341A1 Therapeutic agent for non-alcoholic fatty liver disease, and screening method for drug candidate compound for treatment or prevention of non-alcoholic fatty liver disease
12/19/2007EP1867340A1 Therapeutic agent for bovine digestive system disease
12/19/2007EP1867333A1 Pharmaceutical composition comprising condensed indole compound
12/19/2007EP1867331A1 Triazole derivative and the use thereof
12/19/2007EP1866412A2 Ghrelin binding nucleic acids
12/19/2007EP1866290A1 Prokineticin 1 receptor antagonists
12/19/2007EP1865975A2 Compositions containing cotinus coggygria extract and use thereof on mucosal tissues
12/19/2007EP1865949A2 Modulators of atp-binding cassette transporters
12/19/2007EP1865947A1 The use of ezetimibe in the prevention and treatment of cholesterol gallstones
12/19/2007EP1865939A2 Metformin methods and formulations for treating chronic constipation
12/19/2007EP1865777A2 Stannsoporfin compositions and administration
12/19/2007EP1497261B1 Phenethanolamine derivatives
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1453806B1 Aminotetralin derivatives as muscarinic receptor antagonist
12/19/2007EP1434567B1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid
12/19/2007EP1422224B1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
12/19/2007EP1420802B1 Increased solubility flavanolignan preparations
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1370521B1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/19/2007EP1339665B1 Nitroderivatives as drugs for diseases having an inflammatory basis
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1292596B1 1,3,8-triaza-spiro¬4,5 decan-4-one derivatives as neurokinin receptor antagonists
12/19/2007EP1286999B1 PYRANO[2,3-c]IMIDAZO[1,2-a]PYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007EP1005341B1 Il-8 receptor antagonists
12/19/2007EP0804440B1 Tricyclic benzazepine vasopressin antagonists
12/19/2007CN101090902A Cgrp受体拮抗剂 Cgrp receptor antagonists
12/19/2007CN101090731A Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
12/19/2007CN101090727A Intraoral disintegration type solid preparation containing povidone iodine
12/19/2007CN101090643A Temporally meal menu for infants
12/19/2007CN101089166A Natural enzymolysis process of trigonella seed
12/19/2007CN101089004A New type of phosphonate-nucleotide compound
12/19/2007CN101088982A Fenofibrate derivative containing nitric ester and its medicinal use
12/19/2007CN101088551A Medicine for treating diseases of liver, gall bladder and pancreas and cancer metastasis
12/19/2007CN101088545A Health medicinal liquor
12/19/2007CN101088544A Medicine for treating stomachache
12/19/2007CN101088530A Medicine micropill and its prepn process
12/19/2007CN101088526A Application of flax root extract in preparing medicine for preventing and treating hepatitis
12/19/2007CN101088525A Prepn process of antidiarrheal Chinese medicine for children
12/19/2007CN101088509A Nutritious health oral liquid of lily polysaccharide
12/19/2007CN101088487A Cosmetic or pharmaceutical composition comprising a condensation polymer, cosmetic treatment method employing said composition, said condensation polymer and preparation method
12/19/2007CN101088420A Stomach nourishing Chinese yam tea with five ingredients
12/19/2007CN101088405A Health food for removing toxin and nourishing and its production process
12/19/2007CN101088403A Health food for slimming and eliminating distension and its production process
12/19/2007CN101088401A Concentrated liquid and its prepn process
12/19/2007CN101088371A Instant colorful noodles
12/19/2007CN101088352A Glossy ganoderma health tea making process
12/19/2007CN100355881C Plant expression carrier plasmid for hepatitis B gene, hepatitis B gene transgenic cell line and its industrialization production application
12/19/2007CN100355786C Polyethylene glycol-modified thymus peptide 1 derivatives
12/19/2007CN100355777C Hepatitis B virus pre-S mutain, and its preparing process and application
12/19/2007CN100355770C Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
12/19/2007CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
12/19/2007CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
12/19/2007CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity
12/19/2007CN100355447C Compound preparation for treating liver fibrosis and its preparing method
12/19/2007CN100355446C Synergistic medicinal composition
12/19/2007CN100355439C Capsule for curing enteritis and bloody flux
12/19/2007CN100355432C Chinese and western compounded drug for treating alveolysis and its preparing method
12/19/2007CN100355428C Preparation technology and use of Chinese herbal medicine phoenix-tail fern
12/19/2007CN100355426C Disodium adenosine triphosphate solid composition for injection and its preparing method
12/19/2007CN100355417C Formulation of 'Duyiwei' with improved bioavailability and drug effect and preparation process thereof
12/19/2007CN100355415C Frozen dry powder injection of astrogalus root and its preparing method
12/19/2007CA2820023A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
12/19/2007CA2549115A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists
12/18/2007US7309713 Use of the non-opiate analgesic drug flupirtine for the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowel syndrome
12/18/2007US7309710 Crystals
12/18/2007US7309706 Method for the treatment of diseases requiring inhibition or a reduction in the activity of pH value-regulating bicarbonate transporter proteins
12/18/2007US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease
12/18/2007US7309504 Therapeutic agent or preventor of hepatitis, TNF- alpha inhibitor, health supplementary food
12/18/2007CA2489763C Pharmaceutical salts of reboxetine
12/18/2007CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer
12/18/2007CA2233042C Specific binding members for human transforming growth factor beta; materials and methods
12/13/2007WO2007142596A1 Use of selected lactic acid bacteria for reducing infantile colic
12/13/2007WO2007142580A1 Novel method for preparation of ammonium salts of esomeprazole
12/13/2007WO2007142510A1 Modulation of the immune system by inositol phospholipids
12/13/2007WO2007142325A1 Preventive or remedy for inflammatory disease
12/13/2007WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain
12/13/2007WO2007142306A1 Highly water-soluble agave inulin, agave inulin-containing product, agave inulin-origin product and by product and method of producing the same
12/13/2007WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME
12/13/2007WO2007142297A1 Composition for prevention/treatment of hepatic disease
12/13/2007WO2007142231A1 Agent for improvement in blood fluidity
12/13/2007WO2007142217A1 1-phenylpyridone derivative
12/13/2007WO2007141285A1 Treatment of gastrointestinal disorders with cgrp-antagonists
12/13/2007WO2007141284A2 Treatment of gastrointestinal disorders with cgrp antagonists
12/13/2007WO2007141253A1 Process for the production of intermediates for the preparation of tricyclic imidazopyridines
12/13/2007WO2007140622A1 Dairy-derived probiotic compositions and uses thereof
12/13/2007WO2007140613A1 Fermented milk product and use thereof
12/13/2007WO2007110730A3 Varenicline standards and impurity controls
12/13/2007WO2007098106A3 Respiratory tract delivery of interferon-tau
12/13/2007US20070287970 Method for systemic drug delivery through the nail
12/13/2007US20070287742 Subsitituted Gamma Lactams As Therapeutic Agents
12/13/2007US20070287732 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection
12/13/2007US20070287726 5-Substituted 1H-Pyrrolo [3,2-B] Pyridines
12/13/2007US20070287721 Pyrazolopyridinyl pyridine
12/13/2007US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
12/13/2007US20070287705 Crf Receptor Antagonists and Methods Relating Thereto
12/13/2007US20070287665 Urotensin-II agonists and antagonists
1 ... 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 ... 1258